Recruiting NA Appendicitis

New treatment option for Appendicitis

Official title Transumbilical Laparoscopic Appendectomy

ClinicalTrials.gov ID: NCT06177418

What this study is testing

What it's testing
Transumbilical laparoscopic appendectomy (TULA) is increasingly favored in the treatment of appendicitis within the realm of minimally invasive surgical approaches. This procedure offers advantages such as superior cosmetic outcomes and reduced postoperative pain.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 5 to 18

You may be able to join if

  • patients undergo appendectomy between 5 and 18 years.

You likely can't join if

  • Comorbidity previous surgery

The study team makes the final eligibility decision.

Where it's taking place

  • Istanbul, Turkey (Türkiye)

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 5 years to 18 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.